Literature DB >> 16204297

Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis.

Prasun K Datta1, Shawn Dhupar, Elias A Lianos.   

Abstract

BACKGROUND: We explored whether inducible nitric oxide synthase (iNOS) driven nitric oxide (NO) production regulates expression of iNOS, endothelial NOS (eNOS), Cyclooxygenase-2 (COX-2), and Hemeoxygenase-1 (HO-1) proteins in a rat model of glomerulonephritis induced by antibody raised in rabbits against rat glomerular basement membrane (anti-GBM).
METHODS: Rats were injected either with non-immune serum (control), or anti-GBM serum. In a group of rats N6-(1-iminoethyl)-L-lysine (L-NIL) was administered prior to injection of anti-GBM serum to inhibit iNOS activity. Urinary nitrite plus nitrate (NOx) excretion was assessed to determine the extent of iNOS inhibition by L-NIL. Urinary albumin excretion was assessed to determine extent of proteinuria. Urinary PGE2 was assessed as a marker of COX activity. Glomeruli were harvested 24 h after injection of anti-GBM serum and ED1, COX-2, iNOS, eNOS and HO-1 expression was analysed by Western blot analysis.
RESULTS: iNOS activity in glomeruli was effectively reduced in L-NIL-treated nephritic animals. In these animals, there was exacerbation of proteinuria and reduction in urinary PGE2 levels without changes in the extent of macrophage infiltration in glomeruli. In nephritic animals, there was an increase in glomerular protein levels of COX-2, HO-1 and iNOS, but not of eNOS. While L-NIL treatment reduced glomerular HO-1, levels of COX-2 and iNOS increased; but not that of eNOS.
CONCLUSIONS: The observations indicate that in glomerulonephritis iNOS-driven NO production acts as a negative feedback regulator of iNOS itself, suppresses COX-2 levels, and maintains HO-1 levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204297     DOI: 10.1093/ndt/gfi135

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Aldose reductase regulates TNF-α-induced inducible nitric oxide synthase expression in human mesangial cells.

Authors:  Jingjing Zhao; Tao Jiang; Hui Li; Yuejuan Zhang; Nong Zhang
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

2.  Nicotine augments glomerular injury in a rat model of acute nephritis.

Authors:  Edgar A Jaimes; Run-Xia Tian; Mahesh S Joshi; Leopoldo Raij
Journal:  Am J Nephrol       Date:  2008-10-10       Impact factor: 3.754

3.  TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner.

Authors:  Mary E Hamby; James A Hewett; Sandra J Hewett
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-12-08       Impact factor: 3.072

4.  Physiological and molecular effects of interleukin-18 administration on the mouse kidney.

Authors:  Kyosuke Yamanishi; Keiichiro Mukai; Takuya Hashimoto; Kaoru Ikubo; Keiji Nakasho; Yosif El-Darawish; Wen Li; Daisuke Okuzaki; Yuko Watanabe; Tetsu Hayakawa; Hiroshi Nojima; Hiromichi Yamanishi; Haruki Okamura; Hisato Matsunaga
Journal:  J Transl Med       Date:  2018-03-07       Impact factor: 5.531

Review 5.  Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases.

Authors:  Anne Grunenwald; Lubka T Roumenina; Marie Frimat
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

6.  Sildenafil (Viagra) protective effects on neuroinflammation: the role of iNOS/NO system in an inflammatory demyelination model.

Authors:  Catarina Raposo; Ana Karolina de Santana Nunes; Rayana Leal de Almeida Luna; Shyrlene Meiry da Rocha Araújo; Maria Alice da Cruz-Höfling; Christina Alves Peixoto
Journal:  Mediators Inflamm       Date:  2013-07-22       Impact factor: 4.711

Review 7.  Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.

Authors:  Fuzhou Wang; Xirong Guo; Xiaofeng Shen; Richard M Kream; Kirk J Mantione; George B Stefano
Journal:  Med Sci Monit Basic Res       Date:  2014-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.